本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rapport Therapeutics, Inc.

44.20
+0.58001.33%
成交量:8.08萬
成交額:357.19萬
市值:21.21億
市盈率:-14.48
高:44.90
開:44.30
低:43.36
收:43.62
52周最高:52.93
52周最低:22.73
股本:4,797.83萬
流通股本:3,039.38萬
量比:0.35
換手率:0.27%
股息:- -
股息率:- -
每股收益(TTM):-3.0525
每股收益(LYR):-2.8633
淨資產收益率:-39.96%
總資產收益率:-25.78%
市淨率:5.01
市盈率(LYR):-15.44

資料載入中...

2026/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

重要事件披露

Form 8-K - Current report
2026/01/07

重要事件披露

Form 8-K - Current report
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities